1/69
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
background
people with depression usually suffer with persistent feelings
causes
neurotransmitters involved include 5-HT, NE, epi, dopamine, glutamate, and acetylcholine
5-HT may be the most important
diagnosis
diagnostic and statistical manual of mental disorders, 5th edition (DSM-5-TR)
HDRS, also known as Ham-D is the most widely used depression assessment scale
DSM-5 criteria
at least 5 of the following symptoms present during the same two week period (must include depressed mood or diminished interest/pleasure):
Sleep - increased or decreased
Interest/pleasure - diminished
Guilt of feelings of worthlessness
Mood - depressed
Energy - decreased
Concentration - decreased
Appetite - increased or decrease
Psychomotor agitation or retardation
Suicidal ideation
** remember --> SIG ME CAPS
concurrent bipolar or anxiety disorders
must rule out bipolar disorder before initiating antidepressant therapy to avoid inducing mania or causing rapid-cycling
benzos should not be used alone; can be problematic in patients with concurrent SUD --> risk for physiological dependence, withdrawal symptoms, and respiratory depression and death
key drugs that can cause or worsen depression
ADHD meds --> atomoxetine (strattera)
analgesics --> indomethacin
antiretrovirals (NNRTIs) --> efavirenz, rilpivirine
CV meds --> beta-blockers (esp. propranolol)
hormones --> contraceptives, anabolic steroids
other -->
antidepressants
benzos
systemic steroids
interferons
varenicline
ethanol
medical conditions --> stroke, PD, dementia, MS, hypothyroidism, low vitamin D, metabolic conditions, malignancy, OAB, ID
natural products
st. john's wort --> enzyme inducer
SAMe
5-HTP
** all increase the risk for serotonin syndrome
drug treatment
the initial choice is based on side effect profile, safety concerns, and patient-specific symptoms
for most patients, SSRI or SNRI is preferred
depression in pregnancy and postpartum depression
psychotherapy is first line for depression during pregnancy
medications may be necessary --> SSRIs are first line options --> there is a warning for use during pregnancy and risk of persistent pulmonary hypertension of the newborn
paroxetine should be avoided due to cardiac effects
SSRIs are preferred for treating postpartum depression
safety issues with antidepressants
MAOIs such as phenelzine, tranylcypromine, and isocarboxazid is restricted
serotonin syndrome can occur with the admin of one or more serotonergic meds --> risk is most severe when an MAOI is combined with another serotonergic med --> higher doses also increase risk
if a med is being DC, it should be tapered over several weeks --> an exception to this rule is fluoxetine because of its long half-life
symptoms of serotonin syndrome
severe nausea
dizziness
HA
diarrhea
agitation
tachycardia
hallucinations
muscle rigidity
BBW and med guides
all antidepressants carry a BBW of possible increase in suicidal thoughts or actions in children, teens, or young adults
medguides are required
lag effect and suicide prevention
all meds must be taken daily and will take time to work
physical symptoms such as low energy will improve within 1-2 weeks but psych symptoms may take a month or longer
SSRIs
increase serotonin
SSRI drugs
citalopram (celexa) --> max dose 40mg/day (20mg/day if >60yo)
escitalopram (lexapro) --> max dose 20mg/day (10mg/day if >60yo)
fluoxetine (proxac) + olanzapine (symbyax) --> take symbyax at night
paroxetine (paxil) --> brisdelle: for vasomotor symptoms
sertraline (zoloft)
SSRI CIs
do not use with MAOIs or linezolid
brisdelle --> pregnancy
SSRI warnings
QT prolongation --> do not exceed citalopram 20mg/day or escitalopram 10mg/day in elderly (>60yo)
SIADH/hyponatremia, fall risk
bleeding
SSRIs SEs
sexual side effects
somnolence, insomnia, nausea, dry mouth, diaphoresis, weakness, tremor, dizziness, HA
most activating --> fluoxetine (take in AM)
most sedating --> paroxetine (take in PM)
SSRI notes
fluoxetine, paxil CR, and sertraline are also approved for PMDD
sertraline is preferred in patients with cardiac risk
SSRI drug interactions
MAOIs and serotonin syndrome or HTN crisis --> do not initiate in patients receiving linezolid or methylene blue due to serotonin syndrome risk
allow a 2 week washout period between MAOIs and SSRIs --> fluoxetine is the only exception due to its long half-life (needs a 5-week washout)
QT prolongation mostly noted with citalopram and escitalopram --> careful for additive QT prolongation risk
increase bleeding risk when used with anticoagulants, antiplatelets, NSAIDs, 5 Es, fish oils
fluoxetine and paroxetine are CYP2D6 inhibitors --> tamoxifen requires conversion to its active form by CYP2D6 --> decreased tamoxifen --> venlafaxine is preferred in combo with tamoxifen
SSRI combined mechanism
SSRI and 5-HT1A partial agonist --> vilazodone (viibryd) --> take with food
SSRI, 5-HT3 receptor antagonist, and 5-HT1A agonist --> vortioxetine (trintellix)
SSRI combo details
CIs --> do not use within 14 days of MAOIs
SEs --> decreased libido, but less sexual SEs than SSRIs and SNRIs
SNRIs
increase 5-HT and inhibit the reuptake of NE
SNRI drugs
venlafaxine (effexor XR) --> depression, GAD, panic disorder, social anxiety --> max dose: 375mg/day (IR)
duloxetine (cymbalta) --> depression, peripheral neuropathy, fibromyalgia, GAD, chronic musculoskeletal pain
desvenlafaxine (pristiq)
levomilnacipran (fetzima)
SNRI CIs
SNRIs and MAOIs
SNRI warnings
SIADH/hyponatremia
fall risk
bleeding
SNRI SEs
similar to SSRIs
increased HR
dilated pupils
dry mouth
excessive sweating
constipation
increased BP (all have risk, especially at higher doses)
SNRI drug interactions
SNRIs and MAOIs can cause HTN crisis or serotonin syndrome if used together --> a washout period is needed
do not initiate in patients receiving linezolid or IV methylene blue due to risk of serotonin syndrome
additive QT prolongation risk with venlafaxine
duloxetine is a moderate 2D6 inhibitor
increased bleeding risk with other drugs that increase bleeding risk
TCAs
block ACh and histamine receptors
secondary amines are selective for NE
tertiary amines are more effective, but have a worse side effect profile
TCA tertiary amines
amitriptyline --> QHS
doxepin --> silenor for insomnia
TCA secondary amines
nortriptyline (pamelor)
amoxapine
desipramine
maprotiline
protriptyline
TCA CIs
do not use with MAOIs, linezolid, or IV methylene blue
TCA SEs
cardiotoxicity --> QT prolongation with overdose (monitor for suicidal ideation, as overdose can quickly cause fatal arrhythmias); orthostasis
anticholinergic --> dry mouth, blurred vision, urinary retention, constipation
weight gain
seizures
falls
TCA notes
tertiary amines have increased anticholinergic properties
TCA drug interactions
MAOIs and HTN crisis --> 2 week washout
additive QT prolongation
DA and NE reuptake inhibitor
bupropion (wellbutrin SR, wellbutrin XL) --> do not exceed 450mg/day due to seizure risk
wellbutrin XL is also approved for seasonal affective disorder
bupropion SR (zyban) --> for smoking cessation + naltrexone (contrave) --> for weight loss
bupropiion SIs
seizure disorder
hx of anorexia/bulemia
use with MAOIs, linezolid, IV methylene blue or other forms of bupropion
bupropion SEs
dry mouth
insomnia, restlessness
tremors/seizures (dose related)
weight loss
sexual dysfunction is rare
bupropion drug interactions
do not use multiple forms of bupropion
increased risk of HTN crisis with MAOIs
MAOIs
inhibit monoamine oxidase, which breaks down catecholamines --> can lead to HTN crisis
MAOI drugs
isocarboxazid (marplan)
phenelzine (nardil)
tranylcypromine (parnate)
selegiline transdermal patch (emsam) --> MAO-B selective
MAOI warnings
DDI and DFI --> if missed, it could be fatal
HTN crisis or serotonin syndrome can occur when taken with TCAs, SSRIs, SNRIs, many other drugs, and tyramine-rich foods
MAOI drug interactions
to avoid HTN crisis and serotonin syndrome, MAOIs cannot be used with drugs that increase epi, NE, DA, or serotonin
CI --> linezolid, lithium, tramadol, opioids, St. John's wort
CI with tyramine-rich foods --> aged cheese, pickled herring, yeast extract, air-dried meats, sauerkraut, soy sauce
foods become high in tyramine when they have been aged, fermented, pickled, or smoked
MAOIs --> keep them separated
to avoid serotonin syndrome and HTN crisis -->
2 week washout is required between MAOIs and SSRIs, SNRIs, TCAs, and bupropion
5 week washout is required when changing from fluoxetine to an MAOI
mirtazapine
remeron
TCA
can help with sleep and appetite as well
CI --> MAOIs, methylene blue, linezolid
SEs --> sedation, increased appetite, weight gain
trazadone
inhibits 5-HT reuptake, blocks H1 and alpha-1 receptors
taken at night for sleep
CI --> MAOIs, methylene blue, linezolid
SEs --> sedation, priapism
nefazodone
inhibits 5-HT and NE reuptake, blocks 5-HT2 and alpha-1 receptors
rarely used due to hepatotoxicity --> BBW
selecting the best antidepressant
the antidepressant selected should incorporate patient-specific info and history
did it work? if an antidepressant was taken at a reasonable dose for 4-8 weeks and did not work well, do not use it again
was it well tolerated? do not choose a treatment that was poorly tolerated in the past
does the patient have comorbid conditions that make a drug a good or poor choice?
cardiac/QT risk
sertraline preferred
do not choose a QT-prolonging drug/dose (high doses of citalopram or escitalopram)
watch for additive QT effects when SSRIs, SNRIs, TCAs, mirtazapine or trazadone are used with other QT prolonging drugs
smoker
bupropion SR is FDA approved for smoking cessation
peripheral neuropathy or pain
consider duloxetine
taking serotonergic antidepressants
avoid multiple serotonergic meds due to risk of serotonin syndrome
increased bleeding risk with anticoagulants, antiplatelets, NSAIDs, and some natural produts
seizure disorder or at risk for seizures
do not use bupropion
pregnant
do not use paroxetine
mild-moderate depression --> psychotherapy is first line
certain SSRIs (escitalopram, sertraline) are first line if using drug therapy
daytime sedation
do not take a sedating drug early in the day (paroxetine, mirtazapine, trazodone)
activating medications taken in the morning are preferred (fluoxetine, bupropion)
insomnia
do not take an activating drug later in the day (bupropion, fluoxetine)
sedating meds taken at night are preferred (paroxetine, mirtazapine, trazodone)
sexual dysfunction
high risk with SSRIs and SNRIs
lower risk with bupropion and mirtazapine
treatment-resistant depression
APA guidelines state that a patient should receive a 4-8 week trial of medication at a therapeutic dose
after this, you can:
increase the dose
augment with buspirone or an atypical antipsychotic --> approved agents are aripiprazole, olanzapine + fluoxetine, quetipaine ER
augment with lithium
antipsychotics
aripiprazole (abilify)
olanzapine + fluoxetine (symbyax)
quetiapine (seroquel)
brexpiprazole (rexulti)
cariprazine (vraylar)
antipsychotic BBW
elderly patients with dementia-related psychosis are at increased risk of death
antipsychotic CI
symbyax --> do not use with MAOIs, linezolid, or methylene blue
antipsychotic SEs
aripiprazole --> anxiety, insomnia, akathisia
olanzapine --> sedation, weight gain, increased lipids, increased glucose
quetiapine --> sedation, orthostasis, weight gain, increased lipids, increased glucose
NMDA receptor antagonist
esketamine --> nasal spray
must be taken under supervision of HCP
REMS
all antidepressant counseling
can cause suicidal ideation
medguide required
can take 1-2 weeks to feel a benefit from this drug and 6-8 weeks to feel the full effect on mood
SSRI counseling
can cause sexual dysfunction and serotonin syndrome
fluoxetine --> take in the morning
SNRI counseling
can cause increased BP, increased sweating, sexual dysfunction, and serotonin syndrome
ghost tablet in stool (pristiq)
TCA counseling
can cause anticholinergic effects and orthostasis
bupropion counseling
can cause insomnia
MAOI counseling
can cause serotonin syndrome
many drug interactions
other antidepressant counseling
trazodone --> take at bedtime; can cause priapism
mirtazapine --> take at bedtime